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Abstract
Natural killer (NK) cells serve essential functions in immunity and reproduction. Diversifying these functions within
individuals and populations are rapidly-evolving interactions between highly polymorphic major histocompatibility
complex (MHC) class I ligands and variable NK cell receptors. Specific to simian primates is the family of Killer cell
Immunoglobulin-like Receptors (KIR), which recognize MHC class I and associate with a range of human diseases. Because
KIR have considerable species-specificity and are lacking from common animal models, we performed extensive comparison
of the systems of KIR and MHC class I interaction in humans and chimpanzees. Although of similar complexity, they differ in
genomic organization, gene content, and diversification mechanisms, mainly because of human-specific specialization in
the KIR that recognizes the C1 and C2 epitopes of MHC-B and -C. Humans uniquely focused KIR recognition on MHC-C,
while losing C1-bearing MHC-B. Reversing this trend, C1-bearing HLA-B46 was recently driven to unprecedented high
frequency in Southeast Asia. Chimpanzees have a variety of ancient, avid, and predominantly inhibitory receptors, whereas
human receptors are fewer, recently evolved, and combine avid inhibitory receptors with attenuated activating receptors.
These differences accompany human-specific evolution of the A and B haplotypes that are under balancing selection and
differentially function in defense and reproduction. Our study shows how the qualitative differences that distinguish the
human and chimpanzee systems of KIR and MHC class I predominantly derive from adaptations on the human line in
response to selective pressures placed on human NK cells by the competing needs of defense and reproduction.
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Introduction
Natural killer (NK) cells are lymphocytes that contribute to both
the immune and reproductive systems. NK cells provide first-line,
innate immune defense against infection [1] and cancer [2], and
through interaction with dendritic cells [3] help initiate the
second-line, adaptive immune response [4]. During embryo
implantation and placentation, NK cells control the trophoblast-
mediated widening of maternal blood vessels necessary to nourish
the fetus throughout pregnancy [5]. Controlling both NK cell
development and effector function is a variety of interactions
between NK cell receptors and their ligands [6], the class I
molecules of the major histocompatibility complex (MHC): called
the HLA complex in humans. Some interactions are conserved,
such as that between human HLA-E and the CD94:NKG2A
receptor [7], whereas others are highly variable, notably those
between HLA-A, B, C and killer cell immunoglobulin-like
receptors (KIR) [8]. Pointing to the clinical importance of these
interactions, various combinations of HLA and KIR factors
associate with the outcome of viral infection, susceptibility to
autoimmune disease, relapse of leukemia following therapeutic
transplantation, and reproductive success [9–11].
The human KIR locus combines gene content variability with
allelic polymorphism [8,12]. This diverse family of NK cell
receptor genes is restricted to simian primates, having expanded
from a single copy KIR3DL gene during the last ,40–58 million
years [13]. In rodents, where KIR genes are expressed in the
brain, but not by NK cells [14], the Ly49 gene family
independently evolved as a variable family of NK cell receptors
for MHC class I [15]. Prosimians have a single, non-functional
KIR3DL gene, but a diversified system of CD94 and NKG2 genes
[13]. Also having a single KIR3DL gene, cattle expanded and
diversified the distantly related KIR3DX gene [16], which in
humans is non-functional. This strong element of species-specific
evolution likely reflects the variety and inconstancy of selection
imposed on NK cells by immune defense and reproduction; the
former being essential for individuals to survive, the latter being
necessary for the survival of populations and species [17]. In this
context of rapidly evolving NK cell receptors, the study of
chimpanzees, our closest living relatives, becomes an imperative,
not only for clinical studies in which the chimpanzee is the
preferred animal model, for example hepatitis C virus infection
[18], but also for defining those aspects of NK cell function that
a r eu n i q u et ot h eh u m a ns p e c i e s[ 1 9 ] .
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G expression is restricted to trophoblast and thus dedicated to
functions associated with pregnancy [20]. Of the highly polymor-
phic genes, only HLA-C is present on trophoblast and able to
interact with the KIR of uterine NK cells [21]. HLA-A, B and C
are expressed by almost all cells of the body and can thus
contribute in general to NK cell responses against infection and
cancer. Although the chimpanzee has well-defined orthologs of all
the human HLA class I genes [22], exploratory studies of
chimpanzee KIR cDNA and one KIR haplotype [23,24], raised
intriguing possibilities: first that only a small minority of KIR genes
is shared by humans and chimpanzees; and second, that the
organization of KIR genes into haplotypes is qualitatively different
in the two species. To test these hypotheses we performed
extensive analysis of chimpanzee KIR haplotype structure and
variation, permitting definitive genetic and functional comparison
with the human KIR system.
Results
Chimpanzee KIR haplotypes do not divide into functional
groups like human A and B haplotypes
From sequence analysis of cDNA [23] and three KIR haplotypes
(Figure 1A), we defined 13 chimpanzee KIR genes. Typing a panel
of 39 individuals identified 16 genotypes (Figure 1B), for which the
component KIR haplotypes were deduced (Figure 1C). Both in
number and gene content difference, chimpanzee KIR genotypes
are within the human range (Figure 1D). Common to the human
and chimpanzee KIR loci are three conserved, framework regions
separated by centromeric and telomeric intervals of variable gene
content [25]. Whereas the human variable KIR genes are evenly
distributed between the two intervals, their chimpanzee counter-
parts are restricted to the centromeric interval, leaving the
telomeric interval both short and empty (Figure 2A).
Although human and chimpanzee each have ten variable KIR
genes, only 2DL5 and 2DS4 are held in common. These two genes
distinguish the human group A and B KIR haplotypes, a difference
correlating with a wide range of clinical effects [10]. KIR2DL5 is
the only inhibitory KIR restricted to B haplotypes, 2DS4 the only
activating KIR of A haplotypes (Figure 2A and 2B). Whereas
human 2DS4 is restricted to the telomeric region and present on
,50% of KIR haplotypes, chimpanzee 2DS4 is restricted to the
centromeric region (Figure 2B) and present on only 8% of
haplotypes (Figure 1C). Also varying between species are the
location of 2DL5 and its linkage disequilibrium (LD). Restricted to
the centromeric region, chimpanzee 2DL5 has absolute LD with
inhibitory KIR2DL8, whereas human 2DL5 has absolute LD with
activating KIR2DS3/S5 and is alternatively found in the
centromeric region, the telomeric region, or both (Figure 2A
and 2B). Thus human-specific evolution of the KIR locus involved
‘colonization’ of the telomeric region of the KIR locus, with
assembly of A and B haplotype gene-content motifs around the
2DS4 and 2DL5 genes, respectively. Consequently, human KIR
haplotypes all have 2DS4 and/or 2DL5, while almost half the
chimpanzee haplotypes (44%; arithmetic sum of the individual
frequencies of haplotypes 1, 6, 9 and 15) lack both of them.
Chimpanzee lineage III KIR are more numerous and
functional MHC-C receptors than their human
counterparts
The ten variable chimpanzee KIR form five pairs within the
centromeric region (Figure 1C and Figure 2A). As shown in
Figure 1B, Pairs 2, 3 and 4 at high phenotype frequency are flanked
on the centromeric side by Pair 1 of intermediate frequency and on
thetelomericside byPair5oflowfrequency.Because Pairs1,3,and
5 have absolute or very high LD (Figure 1C), gene-content diversity
of chimpanzee KIR haplotypes derives from asymmetric recombi-
nation between seven units, these three high LD pairs and the
individual genes of Pairs 2 and 4. In humans, a similar number of
units is divided between the centromeric and telomeric regions and
separated by a unique and repetitive sequence that facilitates
symmetric recombination [26] (Figure 2A). Thus recombination of
centromeric and telomeric gene-content motifs, a major component
of human KIR haplotype diversification, is not a significant feature
of the chimpanzee system.
Eight variable chimpanzee lineage III KIR have no human
equivalents and represent lineage III KIR encoding high-avidity
receptors for the C1 and C2 epitopes of MHC-C. Two inhibitory
and one activating KIR are C1-specific, four inhibitory and one
activating KIR are C2-specific [27,28]. Contrasting with this
battery of potent MHC-C receptors is the set of six variable
human lineage III KIR without chimpanzee equivalents. These
comprise high-avidity inhibitory receptors for C1 (2DL2/3) and
C2 (2DL1), a C2 receptor with lower avidity (2DS1) and three
KIR with no detectable binding to HLA class I (2DS2, 2DS3, and
2DS5) [29]. The lineage III KIR expansion associated with
hominid evolution and ‘first’ detected in the orangutan [30] was
further elaborated in chimpanzee and human, but in distinctive
ways. Whereas the chimpanzee retains a diversity of strong
inhibitory and activating MHC-C receptors, the human system is
characterized by a reduced number of inhibitory receptors and a
variety of activating receptors with loss of function [29].
Recombination of ligand-binding and signaling domains
diversifies chimpanzee KIR function
The 3DL3 and 2DL8 genes are represented on each of the
sequenced KIR haplotypes by alleles that encode the same
Author Summary
Natural killer (NK) cells are versatile lymphocytes that make
essential contributions to immune defense and placental
reproduction. Essential to NK cell development, diversifi-
cation and function are variable families of surface
receptors that recognize equally variable determinants of
polymorphic major histocompatibility complex (MHC) class
I molecules, better known as the tissue types matched in
clinical organ transplantation. These ligand-receptor inter-
actions evolve rapidly, exhibiting much species specificity
and convergent evolution. Consequently, mice represent a
poor model, because their receptors are so disparate from
the independently evolved human counterparts that are
restricted to simian primates. To identify unique and
shared aspects of human NK cell biology, we have defined
the genomics, population biology, and immunology of
variable chimpanzee NK cell receptors and ligands to a
level permitting accurate, informed comparison with the
well-characterized human system. In both receptors and
ligands there are dramatic, qualitative differences between
humans and chimpanzees. We show these differences
arose during human evolution from the last common
human–chimpanzee ancestor, while the chimpanzee
system remained relatively stable. That two so closely
related species exhibit major differences in NK cell
receptors and ligands testifies to the strong and varying
selection imposed by the different demands and compet-
ing needs of defense and reproduction.
Major Human and Chimpanzee Immune Divergence
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reciprocal manner, the same cytoplasmic tail can be associated
with different extracellular domains. Thus, the T3 tail is
alternatively associated with the extracellular domains of 3DL3,
2DL9 and 2DL6, as is the T7 tail with the 2DL8, 3DL5 and 2DL7
extracellular domains (Figure 3A and 3B). These chimeric forms
are the products of intergenic recombination that brought together
the extracellular domains of one KIR with the signaling domain of
another. The effect of this mechanism is to generate receptors with
altered inhibitory signaling function (Figure 3C and 3D). For
example, of the three tails associated with 3DL3, T1 has no
immunoreceptor tyrosine-based inhibitory motif (ITIM), T2 has
Figure 2. Human and chimpanzee KIR haplotypes differ in their organization and generation of diversity. (A) Diversity in chimpanzee
arises from the variable recombination of seven units in the centromeric region, whereas a similar number of human gene-content motifs is divided
between the centromeric and telomeric regions. C1 or C2 specificity for each lineage III KIR is shown. Dotted lines indicate orthologs (between
species) or alleles (within species). Y, KIR pseudogene. (A–B) KIR associated with A haplotypes are red; KIR associated with B haplotypes are blue.
Chimpanzee KIR having no human strict ortholog are colored green. (B) Linkage to KIR2DL5 in human and chimpanzee. For each KIR an association
ratio with 2DL5
+/2 haplotypes is given (for example KIR3DS1 is seven times more common on 2DL5A
+ haplotypes than on 2DL5A
2 haplotypes); 2DS3/
5 ratios are given in parenthesis to reflect an assumption (see Materials and Methods for details). Black boxes, reference gene for the linkage analysis
(+, presence; 2, absence). Ratios for framework KIR are shaded in gray. AL, absolute linkage. Linkage disequilibrium was assessed in chimpanzee and
(*) indicates significance (p,0.001).
doi:10.1371/journal.pgen.1001192.g002
Figure 1. Chimpanzee and human KIR genotypes are comparably diverse. (A) Shows KIR gene content of three chimpanzee haplotypes.
Arrows indicate equivalent genes; dotted arrows, divergent alleles. Lineage III KIR are colored blue (MHC-C1 specific) or pink (MHC-C2 specific); names
of activating KIR are red. Y, KIR pseudogene. Haplotype names are from panel (C). The flanking non-KIR genes are colored gray. (B) KIR gene content
was assessed in 39 chimpanzees. The 16 distinct genotypes characterized and their frequencies are given here. Thirteen KIR loci defined by analysis of
cDNA [23] and of the three haplotype sequences of panel A were investigated. KIR phenotype and genotype frequencies are also given for the
subgroup of 26 unrelated individuals. (C) Component KIR haplotypes were deduced from the genotype data presented in panel B, and presented
here with their estimated frequencies. KIR gene and haplotype frequencies are also given for the subgroup of 26 unrelated individuals. ‘Genes’ gives
the number of KIR per haplotype (‘All’), and the number of activating receptor genes (‘Act’). Chimpanzee KIR haplotype diversity stems from
recombination involving five pairs of variable KIR: for each pair the top percentage indicates the observed ‘pairing frequency’ (genes both present or
both absent) and the bottom percentage is the expected ‘pairing frequency’ under random distribution. *, significant linkage disequilibrium
(p,0.001). Red boxes denote the sequenced haplotypes. (D) Both in number and gene content difference, chimpanzee KIR genotypes are within the
human range (see Materials and Methods for details). CI, confidence interval.
doi:10.1371/journal.pgen.1001192.g001
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PLoS Genetics | www.plosgenetics.org 4 November 2010 | Volume 6 | Issue 11 | e1001192Figure 3. Reassorting inhibitory signaling and ligand-binding functions contributes to chimpanzee but not human KIR allelic
diversity. (A) Structural relationships between the three chimpanzee haplotypes. ‘Ig’ and ‘Tail’ refer to the exons encoding the immunoglobulin-like
domains and the cytoplasmic tail, respectively. Colors for the genes are as in Figure 2. (B) Chimpanzee inhibitory KIR associate with different
cytoplasmic tails on different haplotypes. Black boxes, combinations seen in genomic sequences; gray boxes, additional combinations seen in cDNA
sequences (see Figure S13). (C) Mapping of the recombination points for the KIR genes with tails 1–3 and 7. Red arrows represent recombination
breakpoints. Regions colored in green are equivalent (allelic) in the two genes. Blue denotes coding regions, gray the 39UTR region, and yellow the
immunoreceptor tyrosine-based inhibition motifs (ITIM). *, stop codon. (D) Sequence diversity of the seven groups of chimpanzee cytoplasmic tails.
One sequence for each group is displayed. Human 2DL1 is used as the reference. Highlighted in gray are the two ITIM, the protein kinase C motif
(PKC) and the casein kinase motif (CK) [38]. (E–F) Chimpanzee (E) and human (F) KIR polymorphism. Domains contributing .50% of the variability are
shaded in gray. Ind., estimate of the number of individuals sampled (‘+’, minimum number). Seq., number of nucleotide sequences. Prot., number of
amino acid sequences. Chimpanzee sequences are given in Figure S14. Human KIR polymorphism was obtained from the IPD-KIR database [32].
doi:10.1371/journal.pgen.1001192.g003
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haplotypes sequenced, points to the prevalence of the phenome-
non and its significant contribution to the functional diversity of
inhibitory chimpanzee KIR. Consistent with this thesis, sequence
variability in the chimpanzee lineage III inhibitory KIR
concentrates in the signaling domain (Figure 3E). However, that
is not the case for human lineage III KIR, for which tail-swapping
has principally served to convert inhibitory to activating receptors
[31], and allotypic variability more evenly distributes between
ligand-binding and signaling domains (Figure 3F). Consequently,
chimpanzee 3DL3 and inhibitory lineage III KIR display more
allelic variability than their human counterparts (Figure 3E and
3F). Particularly striking is 3DL3, for which four chimpanzee
allotypes have 11 variable positions, compared to 12 in 31 human
allotypes [32].
Divergent sublineages of lineage III KIR encode human
and chimpanzee MHC-C receptors
The genomic regions containing the lineage I, II, and V KIR
genes are shared by human and chimpanzee KIR haplotypes
(Figure 2A, Figure S1, and Figure S2). In contrast, the regions
containing the lineage III KIR genes have diverged to form four
sublineages (Figure 4A). Of these, two are chimpanzee-specific,
one is human-specific and one is shared. The two chimpanzee-
specific sublineages correspond precisely to C1- and C2-specific
KIR. Functionally, these sublineages were lost during human
evolution (a non-functional remnant is KIR3DP1), being replaced
by the human-specific sublineage that includes both C1- and C2-
specific receptors. The shared sublineage includes additional
chimpanzee inhibitory C2 receptors and 2DS4. The differences in
the MHC-C system of receptors in human and chimpanzee are
seen to be mainly the result of human-specific evolution. These
differences alter basic functional characteristics such as the
number and avidity of receptors (Figure 4B), suggesting that
natural selection played distinctive roles in the evolution of human
and chimpanzee lineage III KIR.
Ligand-binding, KIR-KIR interaction, and signaling
function were all subject to natural selection
Evidence of positive diversifying selection was obtained for 16
positions in the ligand-binding domains of hominoid lineage III
KIR (Figure 4C and Figure 5A). These positions cluster at four
sites on the molecular surface: the MHC-C binding site, a site near
the hinge where D1 and D2 interact (D1–D2 site), a site on D1
away from the interactions with D2 and MHC-C (D1 distal site),
and a similarly distal site on D2 (D2 distal site).
Crystallography defined the MHC-C binding site [33,34], and
mutagenesis identified D1–D2 sites that modulate avidity for
MHC-C (Figure 4D). In both sites there was species-specific
selection. Residues 44, 68 and 71 were subject to selection in
chimpanzee, compared to residues 16 and 70 in humans. At
positions 44, 68, and 71, chimpanzee inhibitory receptors have
residues absent from their human counterparts, while the human
evolution of low-avidity activating KIR introduced unique human-
specific residues at positions 44, 70 and 131 (Figure 5B). Thus the
independent evolution of human and chimpanzee lineage III KIR
involved fixation, under natural selection, of species-specific
residues at sites affecting binding of MHC class I ligands.
Five of the 16 selected positions in D1 and D2 are implicated in
the intermolecular KIR-KIR interaction observed in the
KIR2DL2-HLA-Cw3 structure [34]: positions 119 and 90 are
direct contact sites and residues 50, 84 and 123 are only 1–3
residues away from a contact site (Figure 4D). This distribution
points to such KIR-KIR interactions being physiologically
relevant, possibly contributing to the aggregation of receptors
and ligands observed in the synapse between an NK cell and its
target cell [35].
In the cytoplasmic tail, positive diversifying selection targeted
three positions (282, 295, and 296) (Figure 4E and Figure 5A).
Position 282 is in the first ITIM that initiates inhibitory KIR
signals by recruiting the tyrosine phosphatase SHP-2 [36].
Favoring such recruitment is alanine 282 [37], fixed in
chimpanzee but present in a minority of human lineage III
KIR. Residues 295 and 296 are part of the protein kinase C (PKC)
site, comprising residues 291–303. Phosphorylation of serine 298
attenuates inhibitory function [38] and is favored by arginine or
lysine residues within the PKC site [39,40]. In chimpanzee, but
not human KIR, positions 295, 296 and 299 (also selected in
chimpanzee KIR: p.0.9, Figure 5A) have residue combinations
that variably involve arginine and lysine, indicating a modulation
of affinity for PKC.
Recurrent loss and gain of MHC-B carrying the C1
epitope recognized by lineage III KIR
Lineage III KIR recognize the C1 and C2 epitopes of MHC
class I. C2 depends upon valine 76 (V76) and lysine 80 (K80), a
motif restricted to a subset of MHC-C allotypes. C1 depends upon
V76 and asparagine 80 (N80), a motif present in subsets of MHC-
C and -B allotypes; 22% of chimpanzee MHC-B allotypes have
C1, compared to only 2.5% for HLA-B (Figure 6A). Ancestral
sequence reconstruction indicates that the last common ancestor of
MHC-B and -C had V76, which remained fixed during MHC-C
evolution, but was replaced by glutamic acid (E76) during MHC-B
evolution (Figure 6B). The V76 observed in modern MHC-B
allotypes arose de novo, by reversion from E76, with at least fifteen
such events having occurred in hominoids (Figure S3).
Of 12 distinct V76-containing HLA-B (Figure 6C), 11 emerged
in modern human populations, either by point substitution (N=8)
or recombination (N=3). Exceptional is the highly divergent
HLA-B73, which combines features of both MHC-C and
chimpanzee and gorilla MHC-B [41]. Eight point mutations
independently introduced V76 and the C1 epitope into a range of
HLA-B allotypes having N80. In contrast, V76 is never present in
HLA-B allotypes having either isoleucine or threonine 80 (33% of
the total), a distribution unlikely to occur by chance (a=0.05).
Likewise all 11 chimpanzee MHC-B allotypes with V76 have N80
(Figure 6A). Thus selection has favored MHC-B variants having
C1 (V76-N80) and eliminated variants having V76-I80 or V76-
T80. A possible mechanism for the latter effect is that HLA-B
allotypes having I80 and T80 carry the Bw4 epitope recognized by
KIR3DL1 [42,43], and that V76 perturbs this interaction while
failing to introduce either C1 or C2.
HLA-B46, a potent KIR ligand, has undergone a selective
sweep in Southeast Asia
Recombination events with HLA-C introduced V76 into three
N80 HLA-B allotypes (Figure 6C). Of these HLA-B*46 rose to
high frequency in Southeast Asia (Figure 6C), where it originated
(Figure 6D) [44] following the arrival of modern humans ,55–
65,000 years ago [45]. During this selective sweep B*46 further
diversified by point mutation to give 14 low-frequency subtypes
(Figure 6C). The B*46 frequencies of 25.4% and 22.9% in the
Yunnan Dai and Guizhou Miao, respectively, are the highest for
any HLA-B allele in populations exceeding one million individuals,
being of a magnitude typical for small, isolated or bottlenecked
populations (Figure S4).
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good educator of KIR2DL3-expressing NK cells [48]. It also gives
individuals the flexibility to express up to four HLA class I isoforms
bearing C1-C2 combinations (Figure 7A). From HLA and KIR
frequencies, we determined the average number per individual of
distinct interactions (ANDI) between KIR2DL receptors and HLA
ligands. In all population groups ANDI ranged from 1.7–2.4, with
a median of 2.0 (Figure 7B and Figure S5). Because of their low C2
and KIR2DL2 frequencies, Southeast Asians have the lowest
ANDI worldwide, despite the significant contribution of B*46
(shown in red in Figure 7B and in Figure S5). When B*46 is
excluded from the analysis, Southeast Asian ANDI values fall out
of the normal range. Thus the rise of B*46 in these populations has
compensated for their reduced frequency of functional ligand-
receptor pairs (Figure 7C, Figure S5, and Figure S6).
The evolution of MHC-B and -C was marked by extensive type
I functional divergence (site-specific rate shift; a=9.9E-22) as well
as more limited type II functional divergence (shift of cluster-
specific amino acid property; a=0.048) (Figure S7A). Of eighteen
locus-specific sites detected, sixteen are in the a1 domain, nine of
them (including three of the four with strongest support) within
residues 66–76 of the a1 helix (Figure 7D) [49], the segment
recombined in forming B*46 [50]. Type I functional divergence
was greater in MHC-C (nine positions, including the four with the
strongest confidence) than MHC-B (five positions). The nine C-
specific positions are fixed in MHC-C but variable in MHC-B and
Old World monkey MHC-B/C. Thus during evolution of MHC-
C to become the major ligand for lineage III KIR, functionally
favorable residues were fixed at positions throughout the a1 helix
(Figure 7D). Conversely, eleven positions exhibiting low type I
divergence distribute evenly between the a1 and a2 domains, all
but one being highly variable peptide-binding residues.
Type II functional divergence was more limited and equally
distributed between MHC-B and -C (two positions each). Notably,
however, this divergence included the valine to glutamate change
at position 76 in the a1 domain of MHC-B (Figure 6B and
Figure 7D). Overall, functional divergence of MHC-B and -C
focused on the a1 helix, while maintaining similarity in the
peptide-binding site. Consequently, the localized recombination
that introduced residues 66–76 from HLA-C, conferred several C-
like functions and selective advantage to the recombinant B*46
allotype [44,51].
Discussion
Since their ancestors separated 6.5–10 million years ago, human
and chimpanzee acquired major differences in KIR haplotype
structure and gene content. These differences arose from
specializations evolved on the human line. For chimpanzee KIR
haplotypes, variable gene content is confined to the centromeric
region, where ten KIR genes are variably found, leaving the
telomeric region empty. During human evolution the telomeric
region was ‘colonized’ to create a second region of gene content
variability. As a consequence of this reorganization, symmetrical
recombination between the centromeric and telomeric regions has
evolved to be a major mechanism for diversifying KIR haplotypes
in humans [26] but not in chimpanzees.
A second major human-specific specialization has been to fix
mutations reducing the avidity of activating KIR for HLA class I,
while retaining high-avidity inhibitory KIR. This process is most
striking for the lineage III KIR that comprise receptors for MHC-
C, the form of MHC class I molecule that became the major
source of KIR ligands (the C1 and C2 epitopes) in the course of
hominid evolution. Chimpanzees have eight lineage III KIR with
no human equivalents, all of which encode high-avidity activating
or inhibitory receptors for C1 or C2 [27,28]. In contrast the six
human lineage III KIR with no chimpanzee counterparts encode
high-avidity inhibitory receptors for C1 and C2 and four
activating receptors, which acquired mutations that caused three
to lose avidity for HLA-C completely and one to have it reduced
[29].
The major consequence of these two specializations is that
humans evolved two distinctive KIR haplotype groups, A and B,
that are under balancing selection, present in all populations, and
differently associated with disease [17]. In contrast, chimpanzee
KIR haplotypes are variations on a theme emphasizing multiple
and variable high-avidity C1 and C2 receptors. The character
of the A haplotypes is closer to that of the chimpanzee KIR
haplotypes: they have genes encoding high-avidity inhibitory C1,
C2 and Bw4 receptors and lack their attenuated activating
counterparts. In contrast, B haplotypes carry genes for the
attenuated activating receptors and distinctive variants of
the inhibitory receptors. Disease associations suggest a basis for
the balancing selection, in that A haplotypes favor successful anti-
viral defense, whereas maternal B haplotypes favor successful
reproduction [10]. Consistent with the evolutionary plasticity of
viruses and other pathogens, the A haplotype KIR genes are more
polymorphic than their B haplotype counterparts [52], as is also
seen for chimpanzee KIR haplotypes. In this context, human-
specific evolution of group B KIR haplotypes can be seen as an
adaptation to life-threatening complications of pregnancy, such
as pre-eclampsia and eclampsia, which have not affected the
chimpanzee. For example, these hypertensive conditions could
have arisen from imbalance between the supply and increased
demands on maternal blood caused by selection to increase
the size of the neonatal human brain, to double that of the
chimpanzee [53].
A third human-specific specialization has been the decreasing
use of MHC-B allotypes as ligands for lineage III KIR. C1
originated in a molecule resembling MHC-B, which with
duplication and differentiation led to the modern MHC-B and -
C [54]. Whereas 22% of chimpanzee MHC-B allotypes retain C1,
Figure 4. Natural selection differentially diversified human and chimpanzee lineage III KIR. (A) Phylogenetic analysis of lineage III KIR
genomic sequences. The Bayesian tree topology is displayed and rooted with the gibbon sequence (blue arrow: midpoint root). Support is indicated
for each node: Bayesian, maximum-likelihood, parsimony and neighbor-joining (top to bottom). Black squares: support is 100 with the four methods.
*, support,50. (B) Lineage III KIR content in human and chimpanzee. Chimpanzee KIR are represented as a combination of Ig and tails with MHC
specificity-determining residue 44 in the D1 domain in brackets. KIR are colored blue (MHC-C1 specific) or pink (MHC-C2 specific). Arrows indicates
genomic (black) or cDNA (blue) Ig-Tail combinations (Figure 3B). (C) D1 and D2 positively selected positions (M8 p.0.95, Figure 5) are marked in red
in the KIR2DL2-HLA-Cw3 three-dimensional structure (PDB file 1EFX [34] represented). (D) KIR-MHC and KIR-KIR interactions for the selected residues:
KIR2DL1-HLA-Cw4 [33] (left); KIR2DL2-HLA-Cw3 [34] (center), and KIRA-KIRB (right). Mutations at residues colored blue can disrupt KIR-HLA interaction
[8,46]. In parenthesis is the number of residues to the nearest contact site. *, P8 is the eighth residue in the peptide bound by HLA-C. (E) Diversity in
the cytoplasmic tails of inhibitory lineage III KIR. Positions with amino acid variation are represented (reference sequence is KIR2DL1). Orange
highlight denotes positively selected position (M8 p.0.95) in one or more of three datasets comprising hominoid (‘All’), chimpanzee (‘Pt’) or human
(‘Hsa’) sequences. Positions underlined correspond to the functional sites described in Figure 3D. *, only detected in the complete dataset (Figure 5).
doi:10.1371/journal.pgen.1001192.g004
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PLoS Genetics | www.plosgenetics.org 8 November 2010 | Volume 6 | Issue 11 | e1001192Figure 5. Analysis of positive selection in the lineage III KIR. (A) Likelihood ratio tests and detection of the D1, D2 and cytoplasmic tail (CYT)
positions positively selected. Analysis was performed for all the hominoid sequences together and with just the human or chimpanzee or gorilla
sequences; the number of sequences in each analysis is indicated in parentheses. For the cytoplasmic tail analyses all the sequences with an early
termination (short tail KIR) were excluded. In addition, because of the risk of recombination between exon 7 and exon 8 (see Figure 3C) a reduced
dataset was also created (CYT-R) where the nine amino acids encoded by exon 7 were discarded and the Pt-KIR2DL9 amino acids encoded by exon 8
were masked. Similarly, because the cytoplasmic tail of KIR2DL3*007 and the D2 domain of KIR2DL1*004 showed evidence of gene conversion,
additional analyses were performed where these sequences were discarded: datasets CYT-R2 and D2-R, respectively. 2DL, two times the difference in
likelihood between the models allowing for positive selection (M2a and M8) and the models that do not (null models: M1a, M7 and M8a). The
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capacity to bind KIR2DL2/3 [46]. Thus the trend for much of
human evolution has been for HLA-C to become the exclusive
source of ligands for lineage III KIR, potentially reducing
competition between NK-cell KIR and T-cell receptors, which
have overlapping binding sites on HLA class I [33,34]. In this
Figure 6. Emergence of MHC-C affected the functional interactions between MHC-B and lineage III KIR. (A) Distribution of the hominoid
MHC-B and -C residues that affect interaction with lineage III KIR. (B) Phylogenetic analysis of the MHC-B and -C sequences (a1–a3 domains). The
maximum-likelihood tree topology was used for the display with PAML M0 branch lengths. The tree was rooted with MHC-E and support is given at
nodes: Bayesian, maximum-likelihood, neighbor-joining and parsimony (top to bottom). *, support ,95 (Bayesian) or ,50 (parsimony). Ancestral
residues were reconstructed for positions 76 and 80 and are given for five nodes where model M0 p.0.95 (residues underlined were obtained with
model M2a; see Materials and Methods). Groups of sequences were collapsed to simplify display; Old World monkey MHC-B/C have similarities to
both hominoid MHC-B and -C. (C) HLA-B allotypes with V76. AF, allele frequency. Populations with HLA-B*73 AF$0.8% are listed; for HLA-B*46,
populations were selected to represent the range of AF. Rec., recombination with HLA-C. PM, point mutation. N/A, not available. (D) Distribution of
HLA-B*46 AF in Southeast Asia. White dots represent sample points.
doi:10.1371/journal.pgen.1001192.g006
significance level (a) is indicated when the null models were significantly rejected. NS, not significant. *: a,0.01. When significant evidence of positive
diversifying selection was obtained, the residues detected with model M8 were listed (underlined residues: p.0.95; boldened residues: p.0.99; **:
p,0.90). (B) Residues observed at the positively selected positions in the D1, D2 and CYT domains. Amino acids unique to one species are
highlighted in yellow. In the summary section, amino acids only found on activating KIR are highlighted in red while those only found on inhibitory
KIR are highlighted in green.
doi:10.1371/journal.pgen.1001192.g005
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functions leaving HLA-A and -B to dominate T cell responses. A
remarkable reversal of this trend occurred in Southeast Asia
during the last ,55–65,000 years [45], where HLA-B*46, a
recombinant allele that carries C1 and functions well as a ligand
for KIR2DL2/3 [46], underwent a selective sweep to become the
most frequent HLA-B allele. Resolution of human hepatitis C virus
infection was associated with homozygosity for KIR2DL3 and its
C1 ligand [55]. The potential benefit of HLA-B*46 is that it allows
individuals to express three or four C1-bearing HLA-B and C
allotypes. Thus the selective sweep of B*46 could have been driven
by epidemic infection caused by a pathogen like the hepatitis C
virus that is preferentially resisted by individuals having enhanced
representation of C1 and its cognate inhibitory KIR. Interestingly,
several reports describe B*46 as a risk factor for various current
infectious diseases (Figure S8), illustrating the dynamic nature of
these polymorphic genetic factors and the variable pressures




A panel of 39 individuals was studied; 35 western chimpanzees,
two eastern chimpanzees, one central chimpanzee, and one
individual of unknown geographical origin. This study was
approved by the Stanford University administrative panels on
human subjects in medical research and laboratory animal care.
Chimpanzee KIR haplotypes
Haplotypes H13 and H2 originate from the RPCI-43 BAC
library (individual: Donald) while H8 belongs to the CHORI-251
Figure 7. MHC-B allotypes that acquire lineage III KIR-binding increase NK cell effector capacity. (A) Summary of the KIR2DL/HLA-B
(magenta) and KIR2DL/HLA-C (blue) interactions. (B) Average number of distinct KIR2DL-HLA interactions (ANDI) (top) and 2DL3PF*C1PF quantity
(bottom; PF, phenotype frequency) in eight human population groups (see Materials and Methods; individual populations are in Figure S5). Area
between the gapped lines is the 25–75 percentile range; area between the dotted lines (top part) is the non-outlier range (Whisker plot with 1.5
coefficient). Colors in the top part are as defined in (A). Population group in purple (bottom part) contains populations with HLA-B*46 phenotype
frequency of 8.7–27.5%. (C) KIR-HLA phenotypic frequencies for five individual populations. Maximum: maximum ANDI assuming Hardy-Weinberg
equilibrium. (D) Type I and type II functional divergence between MHC-B and -C a1–a2 domains. Positions characterized in this analysis are listed at
the top of the panel, and black boxes indicate in which analysis these positions were characterized. ‘high’ refers to functional-divergence analyses
while ‘low’ refers to an analysis to detect low functional divergence. MHC-B specific sites (indicated by a ‘B’) are defined as divergent in the MHC-B vs.
MHC-C and MHC-B vs. Old World monkey-B/C comparisons but not in the MHC-C vs. Old World monkey-B/C comparison. The same approach was
used for the MHC-C specific positions (indicated by a ‘C’). ‘All’, functionally-divergent in all pairwise comparisons. Underlined residues have better
support (Figure S7). The gray box indicates residues that are in the recombinant region of HLA-B*46. Arrows indicate Peptide [73], TCR [74] and KIR
[33,34] contact sites.
doi:10.1371/journal.pgen.1001192.g007
Major Human and Chimpanzee Immune Divergence
PLoS Genetics | www.plosgenetics.org 11 November 2010 | Volume 6 | Issue 11 | e1001192BAC library (individual: Clint). The final sequence of the H13
haplotype (clone RP43-84K19) has ‘finished sequencing’ quality
(see Text S1 for details). H8 is a previously undescribed haplotype
(Genbank accession number: AC155174) sequenced by the
Washington University Genome Sequencing Center as part of
the chimpanzee genome project. H2 was reported previously [24].
KIR nomenclature and lineages
KIR genes and alleles were named by the KIR Nomenclature
Committee [56]. A curated database is available at http://www.
ebi.ac.uk/ipd/kir/ [32].
KIR gene names reflect the structure of the molecules they
encode: following ‘KIR’, the first two characters give the number
of Ig-like domains in the molecule (KIR3D have three Ig-like
domains for example), and the third character is either a ‘L’, ‘S’ or
‘P’ to indicate ‘Long’ (inhibitory) or ‘Short’ (activating) cytoplasmic
tails, or a pseudogene, respectively. To simplify the text in this
manuscript, the acronym KIR is sometimes omitted.
Based on phylogenetics, the Ig-like domains form three groups:
D0 (most membrane distal of KIR3D), D1, and D2 (most
membrane proximal). Based on domain structure and phyloge-
netic comparison, human KIR are seen to form four distinct
lineages: KIR of the lineages III (3DL1-2) and V (3DL3) have
three Ig-like domains, while KIR of the lineages I (2DL4-5) and III
(2DL1-3, 2DS1-5) have two, with D0-D2 and D1-D2 configura-
tion, respectively.
KIR expression study and MHC-specificity
Assessment of the expression and domain structure of the KIR
encoded by genes present on the three chimpanzee KIR haplotypes
sequenced was performed using peripheral blood mononuclear
cells from the two individuals whose genomic DNA was used to
construct the BAC libraries RPCI-43 and CHORI-251 (results are
summarized in Figure S9; see Text S1 for details). Data on the
MHC specificity of chimpanzee lineage III KIR are from
references [27] and [28]. Changes to the nomenclature of
chimpanzee KIR sequences are described in Text S1 and in
Figure S10.
KIR genomic analyses
Complete gene sequences were aligned and divided into 14
segments, as previously described [30]. Each segment was
analyzed with four methods: Bayesian, maximum-likelihood,
neighbor-joining and parsimony. For the lineage III KIR genes,
a full gene analysis was performed on all fourteen segments.
Additional details are in Text S1.
KIR content and haplotype structures in chimpanzee
For five of the 14 KIR (2DL4, 2DL5, 3DL1/2a and b, and 3DL5),
KIR content was determined as previously described [23], and for
the other nine KIR a new typing system was developed. KIR
haplotype structures were predicted from genotype data using the
HAPLO-IHP program [57], which was originally designed to
reconstruct such haplotypes. Additional details are in Text S1.
KIR genotype diversity and linkage disequilibrium
analysis in human and chimpanzee
To compare genotype diversity in human and chimpanzee, data
from human populations from Africa [58], Europe [59], and Japan
[60] were used. Because the chimpanzee panel has 26 unrelated
individuals, human population data were resampled to give
population sizes of n=26. The mean, standard deviation, and
95% confidence interval for the number of genotypes in human
populations were obtained from 5,000 such resamplings. Mean and
standard error for the pairwise difference between genotypes were
estimated using a bootstrap approach, as implemented in MEGA4
[61]. Presence/absence of each of the 14 chimpanzee KIR of
Figure1Bwasconsidered a single-nucleotide polymorphismandthe
bootstrap procedure was used to shuffle the column content (10,000
bootstrap replicates) before pairwise comparisons were performed.
Data from the chimpanzee panel were then compared to data
obtained from human populations using the same approach [62].
For chimpanzee KIR, linkage disequilibrium (LD) was investi-
gated from the haplotype data of Figure 1C using DNASP [63];
significance was assessed using a 2-tailed Fisher’s exact test. For
human and chimpanzee, we also investigated KIR haplotype
structures using KIR2DL5 as a reference. In these analyses, gene
linkage to 2DL5
+/2 was estimated for each KIR as a ratio: for
example KIR3DS1 is seven times more common on 2DL5A
+
haplotypes than on 2DL5A
2 haplotypes. All ratios were normal-
ized to account for the difference in frequency between 2DL5
+ and
2DL5
2 haplotypes. In the human locus, KIR2DS3/5 can occupy
two different genomic locations [64,65] and linkage between 2DL5
(A or B) and 2DS3/5 was assumed to be absolute, as supported by
currently available haplotype sequences. Gene linkage to 2DL5 in
human was assessed from Caucasian individuals [66].
Selection analysis
dN/dS (v) ratios were estimated by maximum-likelihood using
PAML4 [67]. Three sets of likelihood ratio tests were conducted to
compare null models that do not allow v.1 with models that do.
Significance was assessed by comparing twice the difference in
likelihood between the models (2DL) to a x2 distribution with one
or two degrees of freedom. Codons with v.1 were identified using
the Bayes Empirical Bayes approach; see Text S1 for details.
MHC-B and -C phylogenetic analysis
A representative set of MHC-B and -C sequences was gathered
and phylogenetic analyses conducted using the approach de-
scribed for the KIR genomic analysis (see Text S1). Ancestral
sequence were reconstructed with CODEML of the PAML4
software package [67], using the marginal reconstruction ap-
proach (see Text S1 for details).
Frequency and distribution of MHC-B/C allotypes
Data for the distribution of the MHC-B and -C residues
affecting interaction with lineage III KIR in hominoids were
compiled using IMGT-HLA and IPD-MHC sequences [32,68]. In
addition, a gorilla MHC-B allotype bearing C1 was identified from
analysis of the gorilla shotgun sequences available at the NCBI
Trace Archive website (http://www.ncbi.nlm.nih.gov/Traces/
home/), and generated by the Sanger Center as part of the
gorilla genome project.
Allele frequencies for C1-bearing HLA-B allotypes are from the
Allele Frequency Net Database [69]; when no population data were
available, the country listed in the IMGT-HLA database [68] is given.
The B46 distribution map was generated using the GMT
software package [70] and a previously developed script [71]; for
this distribution, only anthropology studies were used, and data
from recent migrant populations were discarded when the
geographical location of the pre-migration population could not
be precisely ascertained.
Divergence analysis
Type I (site-specific shift of evolutionary rate) and type II (site-
specific shift of amino acid property) functional divergence
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functional divergence analysis a likelihood ratio test was used to
test the null hypothesis that the coefficient of functional divergence
equals zero: twice the difference in likelihood was compared to a
x2 distribution with one degree of freedom. For the type II
functional divergence analysis significance was assessed by a two-
tailed Z-test. Functional divergence-related residues were identi-
fied through the use of cutoffs (see Figure S7 for additional details).
Average number of distinct interactions (ANDI)
Using KIR and HLA phenotypic frequencies (PF) in 33 human
populations (see Figure S11 for details) we determined the average
number of distinct interactions between HLA-C1/C2 and
KIR2DL1-3 (sum of KIR and HLA receptor-ligand pairings)
with the following formula: (2DL1PF*C2PF)+(2DL2PF*C2PF)+
(2DL2PF*C1PF)+(2DL3PF*C1PF). For East Asian populations we
also added the interaction between HLA-B*46 and KIR2DL2-3:
(2DL2PF*B46PF)+(2DL3PF*B46PF). An alternative model where
the interaction between KIR2DL2 and HLA-C2 was not taken
into account was also considered but the results were similar (see
Figure S12).
Statistical testing
In addition to the statistical tests described in individual sections,
a binomial distribution was used to assess the probability that the
substitutions that recurrently created V76 in HLA-B allotypes
always occurred on allotypes with N80 by chance, and the Pearson
product-moment was used to study the correlation between KIR
and HLA frequencies in human populations.
Supporting Information
Figure S1 Phylogenetic comparison of human and chimpanzee
KIR haplotypes. (A) Intron-exon structure of a typical KIR gene
showing the 14 datasets used in phylogenetic analyses. (B–F)
Pairwise comparison of haplotypes: H13 (top) - H2 (left) (B); H8
(top) - H2 (left) (C); H13 (top) - H8 (left) (D); H13 (top) - human A
(E) and H13 (top) - human B (F). Phylogenetic analyses were
performed individually for the 14 segments defined in (A) using
Bayesian, maximum-likelihood (ML), neighbor-joining (NJ) and
parsimony methods (Figure S2). Colored squares indicate
segments equivalent in the two haplotypes and colors reflect the
phylogenetic support (Bayesian: posterior probability (PP), other
methods: bootstrap proportion, BP): dark green squares have
PP.95 and BP $80; light green squares are supported by three of
the four methods (PP $90, BP $50) and orange squares by two of
the four methods (PP $90, BP $50). Red squares indicate a
segment with no equivalent in the other haplotype. Yellow
squares: lack of resolution or trans-species polymorphism (chim-
panzee alleles are mixed with orthologs from different species)
(panels B–D) or phylogenetic group contains at least three
sequences (two from one species and one from the other species)
and the relationships between these sequences are not resolved
(panels E–F). Tan squares: unresolved relationships between three
chimpanzee sequences. Blue lines indicate conserved segments
between the two haplotypes. Colors around the KIR gene names
indicate the lineages: I (green), II (orange), III (purple) and V (red).
(E–F) Orange: human and chimpanzee sequences are mixed with
orthologs from other species.
Found at: doi:10.1371/journal.pgen.1001192.s001 (0.05 MB PDF)
Figure S2 Phylogenetic analysis of the 14 genomic segments
used to compare KIR haplotypes. The phylogenetic reconstruction
was performed on each of the 14 segments described in Figure
S1A using Bayesian, ML, NJ and parsimony approaches. The
Bayesian tree topology was used for the display (with a midpoint
rooting) and the support with the four methods indicated for all the
nodes (from top to bottom: Bayesian, ML, NJ and parsimony).
Black circles at nodes indicate a strong phylogenetic support:
posterior probability (PP) .95 in the Bayesian analysis and
bootstrap proportion (BP) $80 with the other three methods. The
node support was omitted for the nodes not supported by at least
two methods (PP $80 and BP $50). *: PP,80 or BP,50.
Found at: doi:10.1371/journal.pgen.1001192.s002 (0.11 MB PDF)
Figure S3 Emergence of MHC-B allotypes with V76. This
phylogenetic tree represents the MHC-B subtree of the tree
presented in Figure 6B with branch lengths estimated using the
PAML codon model M2a. The names of allotypes with both V76
and N80 are blue while the names of allotypes with V76 but not
N80 are green. Boxes along branches indicate amino acid changes
at position 76 in the a 1 domain: from glutamic acid to valine
(blue) or from valine to glutamic acid (red) (dark colors: p of
change.0.95; light colors: p,0.95). At nodes, boxes indicate the
phylogenetic support in the maximum likelihood analysis: yellow
(BS $50) or green (BS $70). #, excluding B*3902. 1, change from
glycine to valine (blue box) or from glutamic acid to glycine (red
box).
Found at: doi:10.1371/journal.pgen.1001192.s003 (0.03 MB PDF)
Figure S4 B*4601 is the only HLA-B allele with an allele
frequency .25% in a large population. The two left-most columns
list the 24 most common HLA-B alleles worldwide and their
respective worldwide allele frequency (AF) in a study of 146
worldwide population samples [71]. Collectively these alleles
represent .70% of worldwide HLA-B AF. Two alleles initially
included (HLA-B*0704 and B*3705) were subsequently excluded
as no data were available for them in the Allele Frequency Net
Database [69]. For each allele we obtained the population with the
highest allele frequency from the Allele Frequency Net Database
[69]; only data from anthropologological studies involving at least
50 individuals were used: these populations and their AFs are listed
in columns 3–4. In column 3, populations shaded in gray have a
modern population size ,150,000 individuals while populations
shaded in dark gray have a modern population size ,50,000
individuals. Columns 5–6 list for each of the 24 HLA-B alleles the
name of the large population with the highest AF, and the AF in
this population. While we set a minimum of ,200,000 individuals
for a population to be included in column 5, all the populations
listed in this column have modern population sizes well in excess of
1,000,000 individuals. AF.25% are shaded in orange.
Found at: doi:10.1371/journal.pgen.1001192.s004 (0.02 MB PDF)
Figure S5 MHC-B allotypes that reacquire binding to lineage
III KIR restore or increase NK cell effector capacity. (A) Summary
of the KIR2DL/HLA-B (magenta) and KIR2DL/HLA-C (blue)
interactions. (B) Average number of distinct KIR2DL-HLA
interactions (ANDI) (top) and 2DL3PF*C1PF quantity (bottom;
PF, phenotype frequency) in 33 human populations. Area between
the gapped lines is the 25–75 percentile range; area between the
dotted lines (top part only) is the non-outlier range (Whisker plot
with 1.5 coefficient). Colors in the top part are as defined in (A).
Populations in purple (bottom part) have HLA-B*46PF of 8.7–
27.5%. SWA, Southwest Asia; OCE, Oceania; NEA, Northeast
Asia; NAM, North America; SAM, South America.
Found at: doi:10.1371/journal.pgen.1001192.s005 (0.03 MB PDF)
Figure S6 Variability of KIR2DL2 and HLA-C2 frequencies in
human populations. Amongst the components of the KIR2DL/
HLA-C interactions HLA-C2 and KIR2DL2 display the widest
range of phenotypic frequencies in populations (Figure 7C). HLA-
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number of distinct KIR2DL/HLA-C interactions (A) and their
combined frequency distribution (B) mimics that obtained with all
KIR2DL-HLA-C interactions (Figure S5) indicating they repre-
sent the main source of HLA-C/KIR2DL variability in human
populations. KIR2DL2 and HLA-C2 frequencies display a
positive correlation (C–D) that amplifies the difference between
populations. Indeed, five of the seven African populations are, for
example, in the high range of the KIR2DL2-HLA-C2 frequencies
(B) while six to eight of the ten Southeast Asian populations are in
the low range of this distribution (B–D) and have KIR2DL3/
HLA-C1 as their main KIR2DL-HLA-C interaction. The
correlation between KIR2DL2 and HLA-C2 frequencies is the
strongest amongst all KIR2DL-HLA-C1/C2 combinations (E),
although the correlation between KIR2DS2 and HLA-C2 is
almost equally as strong due to the strong linkage disequilibrium
between KIR2DL2 and KIR2DS2. (A) Pearson product-moment
correlations between the average number of distinct interactions
(ANDI) and HLA-C1/C2, KIR2DL1-3 phenotypic frequencies. *,
Average number of distinct interactions excluding the interactions
involving HLA-B*46 and the Nasioi population (see panels C-E).
(B) (2DL2PF*C2PF) quantity in 33 populations. Dark gray area
represents the 25-75 percentile range. (C-D) Pearson product-
moment correlations between KIR2DL2PF and HLA-C2PF in 33
(C) or 32 (D) populations. The red point in (C) is an outlier (Nasioi
population) and was removed for the analysis in (D). (E) Pearson
product-moment correlations between HLA-C1/C2 and
KIR2DL1-3 phenotypic frequencies. The Nasioi population was
consistently an outlier, indicating that the HLA-C1/C2 and
KIR2DL1-3 frequencies in this population have evolved differ-
ently than in the other 32 populations.
Found at: doi:10.1371/journal.pgen.1001192.s006 (0.12 MB PDF)
Figure S7 Functional divergence between the a 1 and a 2
domains of MHC-B and MHC-C. (A) Summary of the type I and
type II functional divergence analyses. h ML: coefficient of type I
functional divergence. h II: coefficient of type II functional
divergence. Significance of the type I analysis was assessed using
a likelihood ratio test (LRT): twice the difference in likelihood
(‘LRT’) was compared to a x 2 distribution with one degree of
freedom. For the type II analysis a two-tailed Z-test was used to
assess the significance. S.E., Standard Error. (B) Identification of
the type I and type II functional divergence-related residues
(defined as having a posterior probability to be functional
divergence-related (p) .h ML/II+0.3 [Gu]). Group-specific residues
are functional divergence-related in all three comparisons while
MHC-B or -C specific positions are related to functional
divergence in two of the three comparisons and display an
average, or lower than average, functional divergence in the third
comparison. For the type I divergence, MHC-B specific positions
were defined as related to functional divergence in the MHC-B/
MHC-C and MHC-B/OWM comparisons (G1: p.h ML+0.3; G2:
p.h ML+0.5) but not in the MHC-C/OWM comparison (G1:
p,h ML+2S.E.; G2: p,h ML-0.3). For the type II divergence,
MHC-B specific positions were defined as related to functional
divergence in the MHC-B/MHC-C and MHC-B/OWM com-
parisons (G1: p.h II+0.3; G2: p.h II+0.5) but not in the MHC-
C/OWM comparison (G1: p,h II+2S.E.; G2: p=0). The same
approach was used for the MHC-C specific positions. OWM, Old
World monkey. (C) Identification of residues with a low type I
functional divergence (defined as having p,h ML-0.3). (D-F)
Results of the type I (D,F) and type II (E) functional divergence
analyses. Functionally-divergent sites are listed at the bottom of
each graph. MHC-B specific sites are colored blue, MHC-C
specific sites are colored red. Sites that are functionally-divergent
in all three comparisons are green, those with a low type-I
divergence are orange. Underlined residues have a better support
(G2 in panel B). Boxed residues are in the recombinant region of
HLA-B*46. Y axis, posterior probability of a site to be functional
divergence-related. [Gu X (2006) A simple statistical method for
estimating type-II (cluster-specific) functional divergence of protein
sequences. Mol Biol Evol 23: 1937-1945.]
Found at: doi:10.1371/journal.pgen.1001192.s007 (0.04 MB PDF)
Figure S8 Disease associations with HLA-B*46. The ‘Disease’
column on the left lists the name of the disease investigated, and
for infectious diseases the name of the causal pathogen. The
country where the study was conducted, the type of association
(resistance ‘R’ or susceptibility ‘S’) and the reference to the study
are given in the ‘Association’ column. The column ‘Significance’
gives the significance of the association between the disease and
HLA-B*46 (‘c’ indicates that this probability was corrected for
multiple comparisons while ‘nc’ indicates no correction for
multiple comparisons). 1, the significance is for a subgroup of
HLA-B*46 haplotypes (listed in ‘Other HLA factors’). The column
‘Other HLA factors’ lists genetic factors also found to be associated
with the disease in the same study, and genetic factors in bold
displayed a more significant association than B*46. Brackets in the
‘Other HLA factors’ column designate haplotypes. #, only in
males. References are: [Wang LM, Kimura A, Satoh M,
Mineshita S (1999) HLA linked with leprosy in southern China:
HLA-linked resistance alleles to leprosy. Int J Lepr Other
Mycobact Dis 67: 403-408. Hananantachai H, Patarapotikul J,
Ohashi J, Naka I, Looareesuwan S, et al. (2005) Polymorphisms of
the HLA-B and HLA-DRB1 genes in Thai malaria patients. Jpn J
Infect Dis 58: 25-28. Chandanayingyong D, Maranetra N,
Bovornkitti S (1988) HLA antigen profiles in Thai tuberculosis
patients. Asian Pac J Allergy Immunol 6: 77-80. Blackwell JM,
Jamieson SE, Burgner D (2009) HLA and infectious diseases. Clin
Microbiol Rev 22: 370-385. Huang X, Ling H, Mao W, Ding X,
Zhou Q, et al. (2009) Association of HLA-A, B, DRB1 alleles and
haplotypes with HIV-1 infection in Chongqing, China. BMC
Infect Dis 9: 201. Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH,
et al. (2003) Association of HLA class I with severe acute
respiratory syndrome coronavirus infection. BMC Med Genet 4:
9. Yoon SK, Han JY, Pyo CW, Yang JM, Jang JW, et al. (2005)
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Found at: doi:10.1371/journal.pgen.1001192.s008 (0.05 MB
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Figure S9 Relationships between chimpanzee KIR cDNA and
gene sequences. Results of the expression study in peripheral blood
mononuclear cells are given for the ten KIR gene sequences with
no prior cDNA equivalent. *, Pt-KIR3DL3 is from the same lineage
as KIR3DL3, a gene expressed at low or undetectable levels in
peripheral blood NK cells.
Found at: doi:10.1371/journal.pgen.1001192.s009 (0.01 MB
PDF)
Figure S10 Sequence and position of Pt-KIR3DS6. (A) Sequence
ofPt-KIR3DL6and 3DS6 attheendofexon7andatthebeginningof
exon 8. Pt-KIR3DL6 has a stretch of seven adenosines at the end of
exon 7 that maintains the typical KIR reading frame for exons 8 and
9, resulting in a protein with two ITIM in the cytoplasmic tail. Pt-
KIR3DS6 has eight adenosines at the end of exon 7: this changes the
typical KIR reading frame for exons 8 and 9, resulting in a protein
with a short cytoplasmic tail with no ITIM. Nucleotides in blue
represent splice sites. The adenosine in red represents the extra base
pair of Pt-KIR3DS6 comparing to 3DL6. (B) Sequencing of exon 7
of Pt-KIR3DL6/S6 in six individuals that typed positives for Pt-
KIR3DL6, including Alex, an individual used in the study where
Pt-KIR3DL6 was characterized [23]. PCR1 and PCR2 represent
two independent PCR amplifications. ‘7A’ and ‘8A’ refer to the
number of adenosines at the end of exon 7, and represent Pt-
KIR3DL6 and 3DS6, respectively. For each amplification and
individual, several clones were sequenced, and the number of clones
ineach categoryismentioned (foreach amplification, the groupwith
the largest number of clones is shaded in gray). (C) Schematic
representation of the gene-to-gene PCR amplification used to
characterize the position of Pt-KIR3DS6. F, forward primer; R,
reverse primer. TM, exon encoding the transmembrane domain;
CYT1-2, exons encoding the cytoplasmic tail. L1-2, exons encoding
the leader peptide.
Found at: doi:10.1371/journal.pgen.1001192.s010 (0.41 MB
PDF)
Figure S11 KIR and HLA frequencies used to establish the
average number of distinct KIR2DL-HLA-B/C interactions
(ANDI) in human populations. AFR, Africa; EUR, Europe;
SWA, Southwest Asia; EAS, East Asia; OCE, Oceania; NEA,
Northeast Asia; NAM, North America; SAM, South America.
Numbers in parenthesis indicate the number of populations in
each group. References are: [69] [Single RM, Martin MP, Gao X,
Meyer D, Yeager M, et al. (2007) Global diversity and evidence for
coevolution of KIR and HLA. Nat Genet 39: 1114-1119. Norman
PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan
RW (2001) Distribution of natural killer cell immunoglobulin-like
receptor sequences in three ethnic groups. Immunogenetics 52:
195-205. Toneva M, Lepage V, Lafay G, Dulphy N, Busson M,
et al. (2001) Genomic diversity of natural killer cell receptor genes
in three populations. Tissue Antigens 57: 358-362. Hoa BK, Hang
NT, Kashiwase K, Ohashi J, Lien LT, et al. (2008) HLA-A, -B, -
C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh
population in Vietnam. Tissue Antigens 71: 127-134. Whang DH,
Park H, Yoon JA, Park MH (2005) Haplotype analysis of killer cell
immunoglobulin-like receptor genes in 77 Korean families. Hum
Immunol 66: 146-154. Lee KW, Oh DH, Lee C, Yang SY (2005)
Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -
DQB1 genes in the Korean population. Tissue Antigens 65: 437-
447. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F,
et al. (2006) Roles for HLA and KIR polymorphisms in natural
killer cell repertoire selection and modulation of effector function.
J Exp Med 203: 633-645. *, some phenotypic frequencies were
estimated from allele frequencies assuming Hardy-Weinberg
equilibrium.
Found at: doi:10.1371/journal.pgen.1001192.s011 (0.02 MB
PDF)
Figure S12 Alternative model for the interactions between
HLA-C and KIR2DL. Unlike the analyses presented in Figure 7,
Figure S5, and Figure S6, the interaction between KIR2DL2 and
HLA-C2 was not taken into account in this model. (A) Summary
of the KIR2DL/HLA-B (magenta) and KIR2DL/HLA-C (blue)
interactions. (B) Average number of distinct KIR2DL-HLA
interactions (ANDI) in 33 human populations. Area between the
gapped lines is the 25-75 percentile range; area between the dotted
lines is the non-outlier range (Whisker plot with 1.5 coefficient).
Colors in the top part are as defined in (A). SWA, Southwest Asia;
OCE, Oceania; NEA, Northeast Asia; NAM, North America;
SAM, South America. (C) Pearson product-moment correlations
between the average number of distinct interactions (ANDI) and
HLA-C1/C2, KIR2DL1-3 phenotypic frequencies. *, excluding
the interactions involving HLA-B*46 and the Nasioi population
(see Figure S6C-E). (D) KIR-HLA phenotypic frequencies for five
individual populations. Maximum: maximum ANDI assuming
Hardy-Weinberg equilibrium.
Found at: doi:10.1371/journal.pgen.1001192.s012 (0.03 MB
PDF)
Figure S13 Domain-by-domain phylogenetic analysis of chim-
panzee KIR sequences. The NJ method was used for the
reconstructions and phylogenetic trees were rooted at the
midpoint. For nodes, the bootstrap proportion support is given
when .50. The eleven cDNA sequences described in the first
study of chimpanzee KIR [23] are colored in blue. The five KIR
lineages are delimited by boxes and are indicated with white
roman letters. (A) D0 domain (or pseudoexon 3). (B) D1 domain.
(C) D2 domain. (D) Stem, transmembrane and cytoplasmic
domains (S/TM/CYT). (E) Full-length coding sequences (includ-
ing the pseudoexon 3). White brackets indicate non-recombinant
alleles. Allelic relationships were established based on the overall
distance in the full-length sequence analysis and consistency in the
domain-by-domain analysis (panels A-D).
Found at: doi:10.1371/journal.pgen.1001192.s013 (0.03 MB PDF)
Figure S14 Summary of KIR polymorphism in chimpanzee.
Amino acid variation is listed for 12 of the 13 chimpanzee KIR for
which such data are available (A-L). For each KIR, the positions of
variability are displayed. The origin of each sequence is given in
parenthesis: Hxx and Tx (KIR haplotypes), cDNA (first cDNA
study [23]), cDNA2 (cDNA sequences characterized in the present
study), and cDNA3 (unpublished sequences deposited in Genbank
with the following accession numbers: AM279149, AM292657-63,
AM396937, and AM400232-36). Position, amino acid residue in
the mature protein. L, leader peptide. D0-D2, Ig-like domains. S,
stem. TM, transmembrane domain. CYT, cytoplasmic tail. FS,
frameshift. *, Stop codon.
Found at: doi:10.1371/journal.pgen.1001192.s014 (0.03 MB
PDF)
Text S1 Supporting text.
Found at: doi:10.1371/journal.pgen.1001192.s015 (0.19 MB PDF)
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